Coloplast AS (CLPBF) reports robust 8% organic growth and a 27% EBIT margin, while addressing challenges in Interventional ...

The Maritime Continent is a term commonly used by meteorologists, climatologists, and oceanographers to describe the region between the Indian and Pacific Oceans including the archipelagos of ...

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and ...

Q1 2025. Management View. CEO Kristian Villumsen highlighted 8% organic growth and a reported EBIT margin of 27% for Q1 2025, w ...

Nancy Parsons, administrative support specialist in the School of Dentistry, is the recipient of the 2024 President’s Award ...

Barclays analyst Hassan Al-Wakeel maintained a Buy rating on ConvaTec (CTEC – Research Report) today and set a price target of £3.20. The ...

Discover the latest research on the management of venous leg ulcers. This Consensus Statement provides concise guidance for healthcare providers in Canada.

In a report released today, Graham Doyle from UBS maintained a Buy rating on ConvaTec (CTEC – Research Report), with a price target of p360.00.

December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported ...

I expect largely steady and healthy trends in the key Ostomy Care and Continence Care businesses. Ostomy should continue to grow around 7% to 8% after a slight dip in FQ4 2024 (6% growth), with ...